Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Perinatal Medicine

Official Journal of the World Association of Perinatal Medicine

Editor-in-Chief: Dudenhausen, MD, FRCOG, Joachim W.

Ed. by Bancalari, Eduardo / Chappelle, Joseph / Chervenak, Frank A. / D'Addario , Vincenzo / Genc, Mehmet R. / Greenough, Anne / Grunebaum, Amos / Konje, Justin C. / Kurjak M.D., Asim / Romero, Roberto / Zalud, MD PhD, Ivica

IMPACT FACTOR 2018: 1.361
5-year IMPACT FACTOR: 1.578

CiteScore 2018: 1.29

SCImago Journal Rank (SJR) 2018: 0.522
Source Normalized Impact per Paper (SNIP) 2018: 0.602

See all formats and pricing
More options …
Volume 43, Issue 2


Placental gene expression of inflammatory markers and growth factors – a case control study of obese and normal weight women

Marianne Allbrand
  • Corresponding author
  • Department of Health and Clinical Science, Örebro University, Örebro, Sweden
  • Department of Obstetrics and Gynaecology, Örebro University Hospital, Örebro, Sweden
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Maria Bjorkqvist
  • Department of Health and Clinical Science, Örebro University, Örebro, Sweden
  • Department of Paediatrics, Örebro University Hospital, Örebro, Sweden
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Kerstin Nilsson
  • Department of Obstetrics and Gynaecology, Örebro University Hospital, Örebro, Sweden
  • School of Medicine, Örebro University, Örebro, Sweden
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ingrid Ostlund / Jan Aman
  • Department of Health and Clinical Science, Örebro University, Örebro, Sweden
  • Department of Paediatrics, Örebro University Hospital, Örebro, Sweden
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-07-11 | DOI: https://doi.org/10.1515/jpm-2013-0343


Objective: To survey the placental gene expression of inflammatory markers and growth factors in non-smoking obese women with an uncomplicated pregnancy without associated morbidity and delivery at term compared with normal weight women.

Methods: Placental tissue samples from 32 obese women (body mass index, BMI≥35.0 kg/m2) were compared with samples from 94 normal weight women (BMI 18.5–25.0 kg/m2) matched for age (±1 year), gestational age (±3 days), parity and mode of delivery. Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to analyse toll receptor-2 and -4, interleukin-6 and -8, tumour necrosis factor-α, leptin, adiponectin, insulin-like growth factor-1 and -2, hepatocyte growth factor, hepatocyte growth factor receptor and insulin receptor.

Results: There was no significant difference in gene expression in placental tissue samples from obese and normal weight women.

Conclusion: We found no difference in the occurrence of inflammatory marker and growth factor mRNA levels in placental tissue samples from a large group of obese women without associated morbidity and with healthy infants compared to a closely matched control group of healthy normal weight women. Compared with the previous studies, this anomalous finding may be explained by the absence of associated morbidity in the obese women in our study.

Keywords: Obesity; pregnancy


  • [1]

    Akram SK, Akram M, Bhutta ZA, Soder O. Human placental IGF-I and IGF-II expression: correlating maternal and infant anthropometric variables and micronutrients at birth in the Pakistani population. Acta Paediatr. 2008;97:1443–8.Web of SciencePubMedCrossrefGoogle Scholar

  • [2]

    Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. Br J Obstet Gynaecol. 2006;113:1126–33.CrossrefGoogle Scholar

  • [3]

    Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009;32:1076–80.Web of ScienceCrossrefGoogle Scholar

  • [4]

    Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008;29:274–81.Web of SciencePubMedCrossrefGoogle Scholar

  • [5]

    Chen J, Tan B, Karteris E, Zervou S, Digby J, Hillhouse EW, et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia. 2006;49:1292–302.CrossrefPubMedGoogle Scholar

  • [6]

    Cseh K, Baranyi E, Melczer Z, Kaszas E, Palik E, Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care. 2004;27:274–5.CrossrefPubMedGoogle Scholar

  • [7]

    Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care. 2007;30:S120–6.CrossrefGoogle Scholar

  • [8]

    Desoye G, Hartmann M, Jones CJ, Wolf HJ, Kohnen G, Kosanke G, et al. Location of insulin receptors in the placenta and its progenitor tissues. Microsc Res Tech. 1997;38:63–75.PubMedCrossrefGoogle Scholar

  • [9]

    Forbes K, Westwood M. Maternal growth factor regulation of human placental development and fetal growth. J Endocrinol. 2010;207:1–16.PubMedCrossrefGoogle Scholar

  • [10]

    Grissa O, Yessoufou A, Mrisak I, Hichami A, Amoussou-Guenou D, Grissa A, et al. Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia. BMC Pregnancy Childbirth. 2010;10:7.PubMedGoogle Scholar

  • [11]

    Guelinckx I, Devlieger R, Beckers K, Vansant G. Maternal obesity: pregnancy complications, gestational weight gain and nutrition. Obes Rev. 2008;9:140–50.PubMedCrossrefWeb of ScienceGoogle Scholar

  • [12]

    Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006;194:1537–45.CrossrefGoogle Scholar

  • [13]

    Kauma S, Hayes N, Weatherford S. The differential expression of hepatocyte growth factor and met in human placenta. J Clin Endocrinol Metab. 1997;82:949–54.PubMedGoogle Scholar

  • [14]

    Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280:E745–51.Google Scholar

  • [15]

    Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51:2207–13.CrossrefGoogle Scholar

  • [16]

    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8.Google Scholar

  • [17]

    O’Reilly JR, Reynolds RM. The risk of maternal obesity to the long-term health of the offspring. Clin Endocrinol (Oxf). 2013;78:9–16.CrossrefGoogle Scholar

  • [18]

    Rasmussen KM, Catalano PM, Yaktine AL. New guidelines for weight gain during pregnancy: what obstetrician/gynecologists should know. Curr Opin Obstet Gynecol. 2009;21: 521–6.CrossrefPubMedGoogle Scholar

  • [19]

    Riley JK, Nelson DM. Toll-like receptors in pregnancy disorders and placental dysfunction. Clin Rev Allergy Immunol. 2010;39:185–93.Web of ScienceCrossrefPubMedGoogle Scholar

  • [20]

    Roberts KA, Riley SC, Reynolds RM, Barr S, Evans M, Statham A, et al. Placental structure and inflammation in pregnancies associated with obesity. Placenta. 2011;32:247–54.PubMedCrossrefGoogle Scholar

  • [21]

    SABioscience. RT2 Profiler PCR Array Data Analysis. QIAGEN [cited 13 Oct 2008]. Available from: http://www.sabiosciences.com/pcr/arrayanalysis.php.

  • [22]

    Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88:2393–8.CrossrefPubMedGoogle Scholar

  • [23]

    Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116:3015–25.CrossrefGoogle Scholar

  • [24]

    Street ME, Seghini P, Ziveri MA, Fieni S, Volta C, Neri TM, et al. Interleukin-6 and insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation. Growth Horm IGF Res. 2006;16:365–72.CrossrefGoogle Scholar

  • [25]

    Waters TP, Huston-Presley L, Catalano PM. Neonatal body composition according to the revised institute of medicine recommendations for maternal weight gain. J Clin Endocrinol Metab. 2012;97:3648–54.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [26]

    Wyatt SM, Kraus FT, Roh CR, Elchalal U, Nelson DM, Sadovsky Y. The correlation between sampling site and gene expression in the term human placenta. Placenta. 2005;26:372–9.CrossrefPubMedGoogle Scholar

About the article

Corresponding author: Marianne Allbrand, Department of Obstetrics and Gynaecology, Örebro University Hospital, S-701 85 Örebro, Sweden, Tel.: + 46 196021268, Fax: + 46 196021080, E-mail: ; and Department of Health and Clinical Science, Örebro University, Örebro, Sweden

Received: 2013-12-19

Accepted: 2014-06-11

Published Online: 2014-07-11

Published in Print: 2015-03-01

Citation Information: Journal of Perinatal Medicine, Volume 43, Issue 2, Pages 159–164, ISSN (Online) 1619-3997, ISSN (Print) 0300-5577, DOI: https://doi.org/10.1515/jpm-2013-0343.

Export Citation

©2015 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

V. Arroyo-Jousse, A. Jaramillo, E. Castaño-Moreno, M. Lépez, K. Carrasco-Negüe, and P. Casanello
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019, Page 165558
Marianne Allbrand, Jan Åman, and Maria Lodefalk
The Journal of Maternal-Fetal & Neonatal Medicine, 2017, Page 1

Comments (0)

Please log in or register to comment.
Log in